DE69425773T2 - Stabile wässrige liposomenhaltige Dispersionen - Google Patents

Stabile wässrige liposomenhaltige Dispersionen

Info

Publication number
DE69425773T2
DE69425773T2 DE69425773T DE69425773T DE69425773T2 DE 69425773 T2 DE69425773 T2 DE 69425773T2 DE 69425773 T DE69425773 T DE 69425773T DE 69425773 T DE69425773 T DE 69425773T DE 69425773 T2 DE69425773 T2 DE 69425773T2
Authority
DE
Germany
Prior art keywords
aqueous dispersions
stable aqueous
containing liposomes
dispersions containing
liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69425773T
Other languages
English (en)
Other versions
DE69425773D1 (de
Inventor
Kenji Endo
Hidekazu Suzuki
Touru Oguma
Masayoshi Goto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Publication of DE69425773D1 publication Critical patent/DE69425773D1/de
Application granted granted Critical
Publication of DE69425773T2 publication Critical patent/DE69425773T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69425773T 1993-04-02 1994-03-31 Stabile wässrige liposomenhaltige Dispersionen Expired - Fee Related DE69425773T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9836793 1993-04-02

Publications (2)

Publication Number Publication Date
DE69425773D1 DE69425773D1 (de) 2000-10-12
DE69425773T2 true DE69425773T2 (de) 2001-06-13

Family

ID=14217915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69425773T Expired - Fee Related DE69425773T2 (de) 1993-04-02 1994-03-31 Stabile wässrige liposomenhaltige Dispersionen

Country Status (4)

Country Link
US (1) US5569464A (de)
EP (1) EP0622072B1 (de)
CA (1) CA2120197A1 (de)
DE (1) DE69425773T2 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2230448A1 (en) * 1995-08-28 1997-03-06 Showa Yakuhin Kako Co., Ltd. Composition for local anesthesia
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
DE19623950A1 (de) * 1996-06-15 1997-12-18 Boehringer Ingelheim Kg Pharmazeutische Zubereitung in Form von Liposomen
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US20020004529A1 (en) * 1997-10-20 2002-01-10 Gary W. Neal Methods, compositions, and kits for enhancing female sexual desire and responsiveness
ATE271376T1 (de) * 1998-02-23 2004-08-15 Cilag Ag Int Liposomale erythropoietin-dispersion
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
KR20020008598A (ko) * 2000-07-24 2002-01-31 김상회 리포좀 화장료 조성물 및 이를 함유하는 부직포
JPWO2002034252A1 (ja) 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
JPWO2002038128A1 (ja) * 2000-11-10 2004-03-11 科学技術振興事業団 小胞体分散液の製造方法
AU3169702A (en) * 2000-12-07 2002-06-18 Yamanouchi Europ Bv Composition for treatment of inflammatory disorders
US20030049158A1 (en) * 2001-04-03 2003-03-13 Hui Poh K. Stablization and terminal sterilization of phospholipid formulations
CA2473719A1 (en) * 2002-01-22 2003-07-31 Wisconsin Alumni Research Foundation Liposome-encapsulated opioid analgesics prepared by rehydration/dehydration method
CA2477979A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for treatment of intracellular infections
DE60327693D1 (de) * 2002-03-18 2009-07-02 Novartis Ag Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
US20050152962A1 (en) * 2002-06-12 2005-07-14 Metselaar Josbert M. Composition for treatment of inflammatory disorders
EP1371362A1 (de) * 2002-06-12 2003-12-17 Universiteit Utrecht Holding B.V. Zusammensetzung zur Behandlung entzündlicher Erkrankungen
EP1393720A1 (de) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesikel enthaltend Corticosteroide zur Behandlung von Krebs
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
EP2363114B1 (de) * 2002-10-29 2015-05-20 Insmed Incorporated Verzoegerte Freisetzung von Anti-infektionsmitteln
DE10255106A1 (de) * 2002-11-24 2004-06-09 Novosom Ag Liposomale Glucocorticoide
US20040228883A1 (en) * 2003-02-21 2004-11-18 Mitchell Karl Prepackaged aqueous pharmaceutical formulation for the treatment of cardiac conditions containing at least two different active agents and method of formulation
AU2004257509B2 (en) * 2003-07-17 2008-12-18 Otsuka Pharmaceutical Co., Ltd. Glycoside-containing liposome
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
SI1888033T1 (sl) 2005-06-09 2014-06-30 Meda Ab Postopek in sestavek za zdravljenje vnetnih motenj
PL1919450T3 (pl) * 2005-09-01 2014-11-28 Meda Ab Kompozycja liposomowa zawierająca lek przeciwhistaminowy i kortykosteroid oraz jej zastosowanie do wytwarzania leku do leczenia nieżytu nosa i chorób spokrewnionych
EP1962805B1 (de) 2005-12-08 2016-07-06 Insmed Incorporated Antiinfektive zusammensetzungen auf lipidbasis zur behandlung von lungeninfekten
US20090047340A1 (en) * 2006-03-29 2009-02-19 Guilford F Timothy Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis
SI2081551T1 (sl) * 2006-10-06 2013-05-31 Scil Technology Gmbh Tvorba posušenega rekonstituiranega vezikla za farmacevtsko uporabo
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
US20110142914A1 (en) * 2007-12-06 2011-06-16 Cytotech Labs, Llc Inhalable compositions having enhanced bioavailability
CH702736B1 (de) * 2008-12-31 2012-12-14 Obschestvo S Organichennoi Otvetstvennostju Scient Company Flamena Phospholipid-Emulsion, die Dihydroquerzetin beinhaltet.
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20110177147A1 (en) * 2010-01-21 2011-07-21 General Electric Company Stable biocidal delivery systems
KR101907411B1 (ko) * 2010-03-12 2018-10-12 베르그 엘엘씨 코엔자임 Ｑ10(ＣｏＱ10)의 정맥내 제형 및 이의 사용 방법
WO2012016048A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti- viral azide-containing compounds
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
EP2667853A4 (de) * 2011-01-25 2014-08-20 Procter & Gamble Liposom- und körperpflegezusammensetzung damit
MX351781B (es) 2011-06-17 2017-10-30 Berg Llc Composiciones farmaceuticas inhalables.
EP2807252B1 (de) 2012-01-26 2017-05-10 Life Technologies Corporation Verfahren zur erhöhung der infektiosität von viren
ITRM20120036A1 (it) * 2012-02-02 2013-08-03 Robert Davis Steigerwalt Jr Applicazione transdermica di prostaglandina e1 per il trattamento dell¿ischemia oculare.
AU2013266400B2 (en) 2012-05-21 2017-06-22 Insmed Incorporated Systems for treating pulmonary infections
US20140023696A1 (en) * 2012-07-20 2014-01-23 Frederick Timothy Guilford Treatment for idiopathic pulmonary fibrosis
EP3581186A1 (de) 2012-11-29 2019-12-18 Insmed Incorporated Stabilisierte vancomycin-formulierungen
US20140234397A1 (en) * 2013-02-15 2014-08-21 Lou Ann Brown Treatment of klebsiella pneumoniae with liposomally formulated glutathione
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
CN204798475U (zh) 2013-03-14 2015-11-25 贝克顿狄金森法国公司 用于可注射氧敏感药物和可注射吗啡的医药包装系统
EP3143988A1 (de) 2013-03-14 2017-03-22 Fresenius Kabi Deutschland GmbH Injizierbare morphinformulierungen
US9895385B2 (en) 2014-05-15 2018-02-20 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
US20170246175A1 (en) * 2014-09-24 2017-08-31 Nanyang Technological University Sustained timolol maleate delivery from liposomes for glaucoma therapy and occular hypertension
ES2704299T3 (es) * 2015-01-21 2019-03-15 Pacira Pharmaceuticals Inc Formulaciones de liposomas multivesiculares de ácido tranexámico
US9855216B2 (en) 2015-05-27 2018-01-02 Ghasem Amoabediny Targeted nano-liposome co-entrapping anti-cancer drugs
CN108291801B (zh) 2015-12-22 2020-11-10 株式会社三丰 用于cmm接触探针的传感器信号偏移补偿系统
US10406117B2 (en) * 2016-02-15 2019-09-10 Kemin Industries, Inc. Water soluble lipophilic materials
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
US11571386B2 (en) 2018-03-30 2023-02-07 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
CN110292565B (zh) * 2019-07-17 2021-09-03 邢瑞 不透过血脑屏障的脂质体复合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746921A (en) * 1980-09-02 1982-03-17 Green Cross Corp:The Oral preparation of human blood coagulation factor
DE3269389D1 (en) * 1981-08-10 1986-04-03 Wellcome Found Pharmaceutical formulations containing antimony
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
JPH02273539A (ja) * 1989-04-14 1990-11-08 Fuji Photo Film Co Ltd リポソームの保存方法
JPH02295917A (ja) * 1989-05-10 1990-12-06 Terumo Corp 内包物の酸化を抑制したリポソームおよびその製法
IT1240354B (it) * 1990-03-30 1993-12-07 Poli Ind Chimica Spa Formulazioni liposomiali di farmaci antimicotici,antibatterici e/o antantiflogistici per applicazione locale e vaginale
CA2046997C (en) * 1990-07-16 2000-12-12 Hiroshi Kikuchi Liposomal products

Also Published As

Publication number Publication date
US5569464A (en) 1996-10-29
EP0622072A2 (de) 1994-11-02
CA2120197A1 (en) 1994-10-03
EP0622072B1 (de) 2000-09-06
DE69425773D1 (de) 2000-10-12
EP0622072A3 (en) 1994-11-17

Similar Documents

Publication Publication Date Title
DE69425773D1 (de) Stabile wässrige liposomenhaltige Dispersionen
DE69319731T2 (de) Wässrige polyurethan-dispersionen
DE59303925D1 (de) Wässrige Polymerisatdispersionen
IT1271014B (it) 3-aril-benzofuranoni come agenti stabilizzanti
DE69612495T2 (de) Wässrige dispersionen auf grund von olefincopolymere
DE59409446D1 (de) Stabile multiple x/o/y-emulsion
DE69314460T2 (de) Schere
DE59407957D1 (de) Beatmungsbeutel
DE69523971T2 (de) Stabile wässrige Festteilchen-Dispersionen
DE59404862D1 (de) Wässrige Polyurethandispersionen
DE59406332D1 (de) Niedrigviskose wässrige konzentrate von betaintensiden
FI945609A (fi) Makromonomeereja sisältävät vesipitoiset lateksit
DE69111851T2 (de) Stabile Dispersionen von Benzotriazol-Ultraviolett-absorbierenden Agenzien.
FI930522A0 (fi) Kaasunkeräysyksikkö
NO930418D0 (no) Innstikkbar helletut
IT1277115B1 (it) Hals-fosforammidi come agenti stabilizzanti
IT1273539B (it) Hals-fosfoniti come agenti stabilizzanti
KR940022049U (ko) 문자가 표시되는 향
KR940020767U (ko) 벽지
DE9317968U1 (de) Schäumende Emulsionen
DE9418622U1 (de) Verbindung
DE69715978T2 (de) Stabile wässrige Dispersionen von Dibutylzinnoxid
DE9320862U1 (de) Entsorgung von Dispersionen
KR940020239U (ko) 발포기
BR9304996A (pt) Solução anti-ácaros

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication of lapse of patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee